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Background: Cells undergoing apoptosis are 
selectively recognized and engulfed by 
phagocytes. 
Results: A Drosophila endoplasmic reticulum 
protein named DmCaBP1 was externalized upon 
apoptosis, bound to both apoptotic cells and 
phagocytes, and enhanced phagocytosis. 
Conclusion: DmCaBP1 connects apoptotic cells 
and phagocytes to promote phagocytosis. 
Significance: This is the first to report that a 
protein residing in the endoplasmic reticulum 




To elucidate the actions of Draper, a 
receptor responsible for the phagocytic 
clearance of apoptotic cells in Drosophila, we 
isolated proteins that bind to the extracellular 
region of Draper using affinity 
chromatography.  One of those proteins has 
been identified to be an uncharacterized 
protein called Drosophila melanogaster 
calcium-binding protein 1 (DmCaBP1).  This 
protein containing the thioredoxin-like 
domain resided in the endoplasmic reticulum 
and seemed to be expressed ubiquitously 
throughout the development of Drosophila.  
DmCaBP1 was externalized without 
truncation after the induction of apoptosis 
somewhat prior to chromatin condensation 
and DNA cleavage in a manner dependent on 
the activity of caspases.  A recombinant 
DmCaBP1 protein bound to both apoptotic 
cells and a hemocyte-derived cell line 
expressing Draper.  Forced expression of 
DmCaBP1 at the cell surface made 
non-apoptotic cells susceptible to phagocytosis.  
Flies deficient in DmCaBP1 expression 
developed normally and showed 
Draper-mediated pruning of larval axons, but 
a defect in the phagocytosis of apoptotic cells 
in embryos was observed.  Loss of 
Pretaporter, a previously identified ligand for 
Draper, did not cause a further decrease in 
the level of phagocytosis in DmCaBP1-lacking 
embryos.  These results collectively suggest 
that the endoplasmic reticulum protein 
DmCaBP1 is externalized upon the induction 
of apoptosis and serves as a tethering 
molecule to connect apoptotic cells and 
phagocytes in order for effective phagocytosis 
to occur. 
 
The prompt and effective removal of cells that 
have become unnecessary or harmful plays an 
important role in the development and tissue 
homeostasis (1, 2).  Such altered own cells are 
induced to undergo apoptosis and become 
susceptible to apoptosis-dependent phagocytosis 
(2, 3).  It is presumed that phagocytes find and 
engulf apoptotic cells using receptors that 
recognize specific ligands present at the surface 
of target cells or soluble molecules connecting 
apoptotic cells and phagocytes (4–6).  It is 
therefore essential to identify and characterize 
the receptors and corresponding ligands/soluble 
molecules in order to fully understand the 
mechanism and meanings of this biological 
phenomenon. 
There are two partly overlapping signaling 
pathways for the induction of phagocytosis in 
Caenorhabditis elegans, and one pathway is 
governed by a receptor called CED-1 (7–11).  
CED-1 is a single-path membrane protein 
containing atypical EGF-like repeats in its 
extracellular region (11).  There are 
counterparts of CED-1 in other species (12), 
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namely Draper in Drosophila (13, 14), Jedi in 
mice (15), and MEGF10 in humans (16), and 
their involvement in the phagocytosis of 
apoptotic cells has been shown.  However, it is 
almost obscure how CED-1 and its counterparts 
are activated for the induction of engulfment in 
phagocytes.  We previously identified a protein 
that we named Pretaporter as a ligand for Draper, 
a Drosophila homologue of CED-1, by affinity 
chromatography (17).  Pretaporter is a protein 
residing in the endoplasmic reticulum (ER)1 and 
seems to be relocated to the cell surface after the 
induction of apoptosis (17).  While isolating 
Pretaporter, we noticed the presence of another 
protein that bound to and eluted from the 
Draper-conjugated matrix.  In the present study, 
we identified and characterized this protein in 





Fly stocks—The following fly lines were 
obtained from the Bloomington Drosophila 
Stock Center (Indiana University, Bloomington, 
IN) and used in this study: w1118, y1 w1118, w*; 
P{sqh-EYFP-ER}3 (18), y1 w67c23; 
P{EPgy2}DmCaBP1EY12345, and w*; wgSp-1/CyO; 
ry506 Sb1 P{Δ2-3}99B/TM6B, Tb+.  The 
Draper-null line w; Sp/SM1; drpr ∆5/TM6B Sb Tb 
(13) was provided by M. Freeman.  To generate 
mutated alleles of DmCaBP1, y1 w67c23; 
P{EPgy2}DmCaBP1EY12345 flies were first mated 
with w1118 6 times to remove possible second-site 
mutations and then with w*; wgSp-1/CyO; ry506 
Sb1 P{Δ2-3}99B/TM6B, Tb+ for the mobilization 
of P-element by the action of Δ2-3 transposase.  
We screened about 100 candidate excision 
events by Western blotting with 
anti-calcium-binding protein 1 of Drosophila 
melanogaster (DmCaBP1) antibody, and isolated 
flies with no DmCaBP1 expression.  A fly line 
obtained after precise excision of P-element, 
DmCaBP1H20, was used as a 
DmCaBP1-expressing control.  Other fly lines 
used were generated through mating of the 
existing lines. 
Cell culture—The cell lines l(2)mbn, 
established from larval hemocytes, and 
embryonic-cell derived S2 were maintained at 25 
°C with Schneider’s Drosophila medium 
(Invitrogen) supplemented with 10% (v/v) 
heat-inactivated FBS, as described previously 
(14).  l(2)mbn cells were incubated with 
20-hydroxyecdysone (Sigma-Aldrich) (1 µM) 
for 48 h before being used in an assay for 
phagocytosis.  To induce apoptosis, S2 cells 
were incubated in the presence of cycloheximide 
(Sigma-Aldrich) (2 µg/ml) for 24 h, as described 
previously (14).  Apoptotic S2 cells were 
stained with the DNA-binding fluorochrome 
Hoechst33342 (1 µM) and by TUNEL 
(Millipore) for the examination of chromatin 
condensation and DNA cleavage, respectively, 
according to standard protocols.  S2 cells were 
treated with E. coli-derived LPS (Sigma-Aldrich) 
(50 µg/ml) at 25 °C for 4 h, essentially as 
reported by Cornwell and Kirkpatrick (19).  To 
fractionate externalized DmCaBP1, culture 
media of apoptotic S2 cells were centrifuged at 
varying levels of forces according to published 
procedures (20), and the resulting pellets and 
supernatants at each centrifugation were 
analyzed by Western blotting.  RNAi using 
double-stranded RNA synthesized in vitro was 
done as described previously (14). 
Antibody and immunochemistry—The 
generation and use of anti-Draper (14), 
anti-Croquemort (14), anti-focal adhesion kinase 
(21), anti-Pretaporter (17), and anti-Calreticulin 
(22, 23) antibodies were reported previously.  
Anti-Drosophila DmCaBP1 antibody was raised 
by immunizing rats with recombinant DmCaBP1 
expressed in E. coli as a protein fused to GST.  
Anti-GST mAb was purchased from Millipore, 
and anti-maltose-binding protein (MBP) 
antibody was from New England Biolabs.  To 
examine the expression of DmCaBP1 during 
development, flies at various developmental 
stages were homogenized in a buffer consisting 
of 63 mM Tris-HCl (pH 6.8), 2.5% (w/v) SDS, 
and 2.5% (v/v) 2-mercaptoethanol, and resulting 
extracts were analyzed by Western blotting.  
For the examination of the binding of DmCaBP1 
to apoptotic cells and phagocytes, we incubated 
cycloheximide-treated S2 cells and l(2)mbn cells 
with GST-fused DmCaBP1 and MBP-fused 
DmCaBP1, respectively, in PBS supplemented 
with 0.88 mM CaCl2 at 4 °C for 1 h, and the cells 
were collected by centrifugation, washed with 
the same buffer, and lysed as described above.  
The lysates were then analyzed by Western 
blotting using anti-GST and anti-MBP antibodies.  
Western blotting using alkaline phosphatase- or 
HRP-labeled secondary antibody was carried out 
as described previously (14).  
Immunocytochemical detection of DmCaBP1 
was performed as described in our previous 
 3 
paper (17).  To immunoprecipitate DmCaBP1, 
cell lysates or culture media were incubated with 
anti-DmCaBP1 antiserum, and proteins bound to 
the antibody were recovered using Protein 
G-Sepharose (GE Healthcare). 
Assays for phagocytosis—Phagocytosis 
reactions in vitro with l(2)mbn cells as 
phagocytes were carried out as described 
previously (14).  To prepare latex beads coated 
with DmCaBP1, FITC-labeled latex beads (Φ = 
1.7 µm; Polysciences) were incubated with 
GST-fused DmCaBP1 in the presence of a 
cross-linking reagent (17).  To obtain 
non-apoptotic cells with surface-expressed 
DmCaBP1, nucleotide sequences of DmCaBP1 
cDNA were altered so that the ER-retention 
motif was replaced by the 
glycosylphosphatidylinositol (GPI)-anchoring 
signal, and S2 cells were transfected with the 
resulting DNA coding for GPI-anchored 
DmCaBP1, as done for Pretaporter (17).  An 
analysis of phagocytosis with dispersed 
embryonic cells was conducted as described (21).  
Briefly, Drosophila embryos at stage 16 were 
homogenized, and cells were collected by 
filtration, fixed with paraformaldehyde and 
methanol, membrane-permeabilized with Triton 
X-100, and incubated with swine serum for 
blocking.  The cells were then cytochemically 
analyzed with anti-Croquemort antibody to 
identify hemocytes and by TUNEL to identify 
apoptotic cells, and cells positive for both signals 
were considered embryonic hemocytes that had 
phagocytosed apoptotic cells.  A microscopic 
field containing 100 or more cells positive for 
Croquemort expression was examined to 
determine the level of phagocytosis.  The mean 
of results from five microscopic fields was 
obtained in each experiment. 
Solid-phase assay for protein-protein 
interaction—GST-fused recombinant proteins 
(2.5 pmoles) were incubated in 96-well culture 
containers, the surface of which had been coated 
with MBP-fused recombinant proteins, at 4 °C 
overnight.  The wells were then washed and 
successively supplied with anti-GST antibody 
and anti-mouse IgG antibody conjugated with 
HRP followed by a colorimetric reaction.  Each 
test protein was analyzed in quintuplicate. 
Other materials and methods—The MS 
analysis was carried out essentially as reported 
previously (17).  In brief, protein bands 
separated by SDS-PAGE and visualized by 
staining with silver or Coomassie Brilliant Blue 
were excised and in-gel-digested with trypsin or 
Achromobacter protease I.  The resulting 
peptides were then subjected to LC-MS/MS, and 
proteins were identified by the MS/MS ion 
search of Mascot Software (Matrix Science, 
London, UK).  The pan-caspase inhibitor 
z-VAD-fmk was obtained from R&D Systems 
and used at 20 µM.  Brefeldin A, 
3-methyladenine, and MG-132 were purchased 
from Sigma-Aldrich and added to cell cultures at 
the concentrations effectively used for 
Drosophila cells: 30 µg/ml (24), 10 mM (25), 
and 10 µM (26, 27), respectively.  An 
extracellular region of Draper fused to GST at 
the C-terminus was expressed in Sf21 cells using 
a baculovirus-based vector and affinity purified, 
as described previously (17).  Other GST-fused 
and MBP-fused recombinant proteins were 
expressed in E. coli using the pGEX-KG (GE 
Healthcare) and pMAL-c4X (New England 
Biolabs) vectors, and purified to homogeneity 
using glutathione Sepharose 4B (GE Healthcare) 
and amylose resin (New England Biolabs), 
respectively, according to the manufacturers’ 
instructions.  Using pGEX-KG proteins of 
interest were fused to GST at the N-terminus, 
and with pMAL-c4X vector proteins were fused 
to MBP at the N-terminus and to β-gal at the 
C-terminus.  Semi-quantitative RT-PCR was 
carried out according to a standard protocol 
using the following DNA oligomers as primers 
in PCR: 5’-CCCGGAGTGAAGGATG-3’ 
(forward) and 5’-GTTGCTGTGCGTCAAG-3’ 




for mRNA of ribosomal protein 49.  An 
analysis of axon pruning was carried out as 
described previously (28). 
Data processing and statistical 
analysis—Data from quantitative analyses are 
expressed as the mean ± S. D. of the results from 
at least three independent experiments, unless 
otherwise stated in the text.  Other data are 
representative of at least three independent 
experiments that yielded similar results.  
Statistical analyses were performed using 
Student’s t test.  Values of p < 0.05 were 






Identification and expression profile of 
DmCaBP1—We previously isolated proteins that 
bind to the extracellular region of Draper and 
identified a protein, which we named Pretaporter, 
as a ligand for Draper (17).  There was another 
protein band that was retained on and eluted 
from the Draper-conjugated Sepharose matrix 
(Fig. 1A).  We analyzed this band by MS (Fig. 
1B and supplemental Fig. S1) and found it to be 
an as-yet uncharacterized protein called 
DmCaBP1 (29).  The amino acid sequence 
deduced from the nucleotide sequence of cDNA 
(AY061349.1) shows that DmCaBP1 consists of 
433 amino acid residues containing the signal 
peptide at the N-terminus, two thioredoxin-like 
domains, and the ER-retention motif at the 
C-terminus (Fig. 1B), suggesting it to be a 
protein residing in the ER.  An ELISA-like 
solid-phase assay revealed that DmCaBP1 
directly binds to Draper (Fig. 1C). 
When the level of DmCaBP1 was analyzed 
with flies at various developmental stages by 
Western blotting, this ER protein continued to be 
expressed from embryos through adults (Fig. 
1D).  To determine the subcellular localization 
and cell type-specificity of DmCaBP1, we 
immunocytochemically analyzed dispersed 
embryonic cells that artificially expressed a 
marker protein for the ER.  The results showed 
that the localization of DmCaBP1 overlaps with 
that of a marker present in the lumen of the ER, 
and that almost all the cells in stage-16 embryos 
gave positive signals (Fig. 1E), indicating a 
ubiquitous expression of DmCaBP1 in the ER at 
least for this developmental stage. 
Apoptosis-dependent externalization of 
DmCaBP1—Since DmCaBP1 was found as a 
protein binding to the extracellular region of 
Draper, we next examined its possible 
externalization.  We first 
immunocytochemically analyzed cultured cells 
before and after the induction of apoptosis.  The 
treatment of cells with cycloheximide, which 
induces typical apoptosis (14), seemed to change 
the subcellular distribution of DmCaBP1 from 
the ER to the area near the plasma membrane 
(Fig. 2A).  We next examined the presence of 
DmCaBP1 in the culture medium by Western 
blotting and observed a signal with migration in 
a gel almost the same as the intracellular one 
(Fig. 2B).  This was not the case for Draper and 
focal adhesion kinase, a membrane-integrated 
and a soluble cytoplasmic protein respectively, 
and the DmCaBP1 signal in the medium 
disappeared when apoptosis was induced in the 
presence of z-VAD-fmk, a caspase inhibitor.  
We previously showed that other ER proteins, 
Calreticulin (23) and Pretaporter (17), exist at the 
surface of apoptotic cells.  We thus examined if 
these proteins are also released from apoptotic 
cells.  However, the results indicated that they 
are not purged from apoptotic S2 cells as 
efficiently as DmCaBP1 (Fig. 2B).  These 
results indicated that DmCaBP1 is preferentially 
externalized after the induction of apoptosis.  
When a time-course experiment was carried out, 
DmCaBP1 became detectable in culture 
supernatants somewhat prior to a couple of 
biochemical events typical of apoptosis: the 
cleavage of nuclear DNA (examined by TUNEL) 
and the condensation of chromatin (examined by 
staining with Hoechst33342) (Fig. 2C). 
A recent report shows that an aminopeptidase 
residing in the ER is secreted from macrophages 
upon treatment with LPS and IFN-γ in a manner 
inhibitable by brefeldin A, suggesting the 
involvement of inflammatory signaling and 
vesicle transport (30).  We conducted a series 
of experiments to examine an analogy in the 
mechanism of externalization between 
DmCaBP1 and this aminopeptidase.  S2 cells 
were incubated in the presence of LPS, and cell 
lysates and culture media were analyzed for the 
presence of DmCaBP1.  The results showed 
that LPS induced the expression of mRNA of 
attacin-A, an antimicrobial peptide, in S2 cells 
but not the externalization of DmCaBP1 
(supplemental Fig. S2A).  To examine the 
involvement of vesicle transport, autophagy, and 
proteasomes in the apoptosis-dependent 
externalization of DmCaBP1, we treated cells 
with cycloheximide together with brefeldin A, 
3-methyladenine, and MG-132, respectively.  
However, the externalization of DmCaBP1 was 
not influenced by the presence of either 
substance (supplemental Fig. S2B).  These 
results suggested that the mechanism for 
externalization differs between DmCaBP1 and 
ER-residing aminopeptidase. 
We next examined if externalized DmCaBP1 
is associated with membrane vesicles.  Culture 
media of apoptotic S2 cells were subjected to 
differential centrifugation, and supernatants and 
pellets after each centrifugation were analyzed 
for the presence of DmCaBP1 by Western 
blotting.  The results showed that supernatants 
but not pellets, which should contain 
membranous materials, after final centrifugation 
gave signals, suggesting that externalized 
DmCaBP1 is not contained in membrane 
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vesicles (Fig. 2D).  We then examined possible 
truncation of DmCaBP1 during externalization.  
For this purpose, we conducted the MS analysis 
of DmCaBP1 immunoprecipitated from lysates 
of normal S2 cells as well as culture media of 
apoptotic S2 cells.  We first analyzed 
trypsin-digested DmCaBP1 and identified a 
peptide spanning the presumed C-terminus (Fig. 
2E).  This peptide existed in the samples 
derived from both intracellular and externalized 
DmCaBP1, and was among abundant peptides 
observed (supplemental Fig. S3A).  We 
concluded that KDEL is the C-terminal sequence 
of mature DmCaBP1, and that this region does 
not undergo cleavage during externalization of 
DmCaBP1.  By contrast, a peptide 
corresponding to the N-terminus appeared 
undetectable in the analysis.  We thus used 
another protease, Achromobacter protease I, to 
digest DmCaBP1 and similarly analyzed the 
resulting peptides.  In this attempt, we observed 
a peptide corresponding to the amino acid 
positions 34–41 (Fig. 2E), and the amount of this 
peptide was near comparable to those of other 
peptides in both samples (supplemental Fig. 
S3B).  There found no peptides located closer 
to the N-terminus of nascent DmCaBP1 than this 
peptide.  We thus presumed that NFDR is the 
N-terminal sequence of mature DmCaBP1, and 
that the N-terminal 33-amino acid region 
including the signal peptide is chopped off 
during the maturation of nascent DmCaBP1.  
Collectively, DmCaBP1 is unlikely to undergo 
truncation upon apoptosis-dependent 
externalization. 
Involvement of DmCaBP1 in phagocytosis of 
apoptotic cells—We next examined if 
externalized DmCaBP1 binds to apoptotic cells 
and/or phagocytes.  For this purpose, we 
incubated cultured cells with GST- or 
MBP-tagged DmCaBP1 and determined 
cell-bound DmCaBP1 by Western blotting.  We 
found that more DmCaBP1 proteins were 
recovered with either apoptotic S2 cells or 
hemocyte-derived l(2)mbn cells than the control 
proteins (Fig. 3A).  This indicated that 
DmCaBP1 binds to both apoptotic cells and 
phagocytes, and suggested a role for this ER 
protein in the phagocytosis of apoptotic cells. 
In order to test the possibility that 
externalized DmCaBP1 binds and activates 
phagocytes, l(2)mbn cells were incubated with a 
recombinant DmCaBP1 protein, washed, and 
used in an assay for the phagocytosis of latex 
beads.  We found that the level of phagocytosis 
by l(2)mbn cells treated with DmCaBP1 did not 
significantly differ from that by the cells 
pre-incubated with a control protein (data not 
shown).  This suggested that DmCaBP1 binds 
to phagocytes but does not augment their general 
phagocytic activity. 
To examine the effect of DmCaBP1 on 
phagocytosis mediated by Draper, we analyzed 
the phagocytosis of DmCaBP1-bound latex 
beads by l(2)mbn cells.  Beads coated with 
GST-DmCaBP1 were more effectively 
phagocytosed than those coated with GST alone, 
and this was abolished when l(2)mbn cells were 
treated with double-stranded RNA with a 
sequence corresponding to Draper mRNA (Fig. 
3B).  Furthermore, forced expression of 
DmCaBP1 as a membrane-anchor form made 
non-apoptotic S2 cells susceptible to 
phagocytosis by l(2)mbn cells (Figs. 3C and 3D).  
These results indicated that DmCaBP1 induces 
phagocytosis, being present at the surface of 
target cells.  To confirm a role for DmCaBP1 in 
apoptotic cell clearance in vivo, we generated a 
fly line deficient in the expression of DmCaBP1 
(Fig. 4A and supplemental Fig. S4) and analyzed 
phagocytosis in embryos.  The results showed 
that the level of phagocytosis was lower in 
embryos of the DmCaBP1-lacking fly line than 
in a control line (Fig. 4B).  The above-described 
results collectively suggested that DmCaBP1 is 
released from cells during apoptosis, bridges 
apoptotic cells and phagocytes, and promotes 
Draper-dependent phagocytosis. 
Functional relationship between DmCaBP1 
and Pretaporter—The results obtained so far 
indicated that DmCaBP1 is analogous to 
Pretaporter, which we previously reported as a 
ligand for Draper (17).  The removal of γ 
neuron axons, called pruning, of larval 
mushroom bodies during metamorphosis occurs 
in a manner dependent on the actions of Draper 
(28), and Pretaporter does not seem to be 
involved in this event (17).  We found that the 
pruning of larval axons almost normally took 
place in the absence of DmCaBP1 while it was 
severely impaired in Draper-lacking flies as 
observed previously (28) (Fig. 4C).  For a more 
direct examination of the relationship between 
DmCaBP1 and Pretaporter, we generated a 
double-mutant fly line that lacks both proteins 
(Fig. 5A) and analyzed its embryos for the 
phagocytosis of apoptotic cells.  We found that 
the level of phagocytosis by embryonic 
hemocytes in the double mutant was comparable 
to that in single mutants for the two genes (Fig. 
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5B).  This suggested that DmCaBP1 and 
Pretaporter cooperate with each other in the 
Draper-mediated phagocytosis of apoptotic cells 




In the present study, we isolated the 
Drosophila protein DmCaBP1 and showed its 
role in the phagocytosis of apoptotic cells.  
DmCaBP1 resides in the lumen of the ER of 
normal cells and is apparently relocated outside 
cells upon the induction of apoptosis.  
DmCaBP1 most likely connects apoptotic cells 
and phagocytes for the induction of phagocytosis.  
We previously reported another ER protein, 
which we named Pretaporter, as a ligand for 
Draper (17).  Genetic experiments in this study 
showed that a simultaneous loss of DmCaBP1 
and Pretaporter does not bring about a further 
decrease in the level of phagocytosis compared 
to flies lacking either one of these ER proteins, 
suggesting cooperation between the two proteins.  
Data obtained from a co-immunoprecipitation 
experiment and a solid-phase binding assay 
suggested no physical association between these 
two proteins (data not shown).  Recently, Wang 
et al. (31) reported that a transthyretin-like 
protein of C. elegans called TTR-52 is secreted 
from non-apoptotic cells and acts as a bridging 
molecule between apoptotic cells and phagocytes 
by binding to phosphatidylserine and CED-1, 
respectively.  As an analogy to this protein, 
DmCaBP1 could act as a bridging or tethering 
molecule to promote phagocytosis.  We 
speculate that both Pretaporter and DmCaBP1 
are essential for the Draper-mediated 
phagocytosis of apoptotic cells, in that 
Pretaporter is responsible for the activation of 
Draper while DmCaBP1 connects apoptotic cells 
and phagocytes. 
Our data suggested that intact DmCaBP1 even 
with the ER-retention motif is released from 
apoptotic cells.  The externalization of 
DmCaBP1 depended on the activity of caspases 
but did not seem to involve vesicle transport, 
autophagy or proteasome.  By contrast, 
Pnaretakis et al. (32) reported that mammalian 
calreticulin is exposed to the surface of apoptotic 
cells by SNARE-dependent exocytosis, and an 
ER-residing aminopeptidase is secreted from 
macrophages upon an inflammatory stimulus in a 
manner involving vesicle transport (30).  
Besides DmCaBP1, two more ER proteins, 
Calreticulin (23) and Pretaporter (17), are found 
at the surface of apoptotic cells.  Unlike 
DmCaBP1 these proteins seemed to directly 
move from the ER to the cell surface without 
being released from cells.  Franz et al. showed 
that several ER-residing proteins, which were 
not analyzed in this study, are exposed at the 
surface of apoptotic cells (33).  Therefore, the 
externalization or surface exposure of ER 
proteins could be a general feature in apoptotic 
cells although the mechanism of relocation may 
vary from protein to protein.  Clarification of 
the mechanisms and meanings of this biological 
event is important for understanding the 
extra-ER role for ER proteins in apoptosis. 
Two proteins, DmCaBP1 and Pretaporter (17), 
isolated through affinity chromatography with a 
matrix containing the extracellular portion of 
Draper turned out to be ER proteins containing 
the thioredoxin-like domain: two and three 
domains are repeated in tandem in DmCaBP1 
and Pretaporter, respectively.  We previously 
showed that two thioredoxin-like domains are 
sufficient for Pretaporter to bind Draper (17), 
and this coincides with the presence of two 
domains in DmCaBP1.  This domain is often 
contained in protein disulfide isomerases that 
catalyze the formation and breakage of disulfide 
bonds (34, 35).  Na et al. showed that human 
protein disulfide isomerase undergoes partial 
cleavage by caspases in apoptotic cells (36).  
However, DmCaBP1 did not seem to undergo 
proteolysis during apoptosis-dependent 
externalization.  To examine a possible effect of 
DmCaBP1 on the expression of Draper, we 
analyzed Draper with lysates of adult flies by 
Western blotting, but found no significant 
difference as to either the signal intensity or the 
electrophoretic mobility on a gel determined 
without 2-mercaptoethanol, irrespective of the 
existence of DmCaBP1 (data not shown).  Flies 
lacking both DmCaBP1 and Pretaporter 
developed normally and showed no obvious 
defects, suggesting that these two ER proteins 
are dispensable.  Roles for DmCaBP1 and 
Pretaporter as proteins containing the 
thioredoxin-like domain and localized in the ER, 
besides their involvement in the 
Draper-mediated phagocytosis of apoptotic cells, 
remain to be elucidated. 
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FIGURE 1. Identification and expression pattern of DmCaBP1.  A, Whole-cell lysates of S2 cells 
were subjected to affinity chromatography using Sepharose conjugated with the extracellular region of 
Draper fused to GST (Draper-GST) or GST alone.  The bound materials were eluted and analyzed by 
SDS-PAGE followed by staining with silver.  The arrowhead points to the position of a band that 
was subsequently identified to be DmCaBP1.  B, The entire amino acid sequence of DmCaBP1 
deduced from the nucleotide sequence of cDNA is shown with the positions of peptides identified in 
the MS analysis (underlined) as well as predicted domain structures.  The numbering denotes amino 
acid positions with the N-terminus as 1.  The boxed, colored (blue and red), and bolded/shaded 
regions indicate the signal peptide, the thioredoxin-like domains, and the ER-retention motif, 
respectively.  Refer to supplemental Fig. S1 for more information.  C, The binding of DmCaBP1 to 
Draper was examined by an ELISA-like solid-phase assay.  GST-fused Draper (Draper-GST) or GST 
alone was incubated in a culture container that had been coated with the indicated MBP-fused proteins, 
and the amount of GST proteins remaining in the container after wash was determined by an 
immunochemical reaction.  The mean ± S. D. of the data (n = 5) from one of two independent 
experiments with similar results are presented.  D, Lysates of whole animals at the indicated 
developmental stages were analyzed by Western blotting for the level of DmCaBP1.  E, Dispersed 
embryonic cells (stage 16) of a fly line, which expresses YFP fused to the ER-retention motif KDEL 
at the C-terminus as a marker for ER-residing proteins (ER marker), were immunocytochemically 
analyzed using anti-DmCaBP1 antibody for the subcellular localization of DmCaBP1.  
Phase-contrast and fluorescence views of the same microscopic fields are shown as laterally aligned 
panels.  The inset shows a magnified view of a cell pointed by an arrowhead in each panel.  Scale 
bar, 20 µm. 
 
FIGURE 2. Apoptosis-dependent externalization of DmCaBP1.  A, S2 cells before and after the 
treatment with cycloheximide were immunocytochemically analyzed for the subcellular localization of 
DmCaBP1.  Fluorescence and phase-contrast views of the same microscopic fields are shown as 
vertically aligned panels.  The arrowheads indicate the cells where the localization of DmCaBP1 has 
been altered.  Scale bar, 10 µm.  B, S2 cells were treated with cycloheximide in the absence and 
presence of the caspase inhibitor z-VAD-fmk, and their whole-cell lysates as well as the culture media 
were analyzed by Western blotting for the levels of the indicated proteins.  Only portions of the gel 
containing the signals derived from the corresponding proteins are shown.  FAK, focal adhesion 
kinase.  C, S2 cells were maintained in the presence of cycloheximide for the indicated periods of 
time.  The culture media were analyzed for the level of DmCaBP1 by Western blotting (WB) while 
the cells were subjected to cytochemical analyses for the occurrence of DNA cleavage (TUNEL) and 
chromatin condensation (Hoechst).  In the analysis of DNA cleavage, TUNEL-positive nuclei are 
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seen in black.  In the analysis of chromatin condensation, fluorescence and phase-contrast views of 
the same microscopic field are shown as vertically aligned panels.  Scale bar, 20 µm.  D, Culture 
media of cycloheximide-treated S2 cells were first centrifuged at 1,500 × g for 3 min, and the resulting 
supernatants were re-centrifuged at 1,500 × g for 20 min.  Supernatants were collected and 
centrifuged at 10,000 × g for 30 min, and the resulting supernatants were re-centrifuged at 110,000 × g 
for 60 min.  Supernatants and pellets obtained after each centrifugation were analyzed by Western 
blotting for the presence of DmCaBP1.  E, DmCaBP1 present in the culture media of 
cycloheximide-treated S2 cells and whole-cell lysates of normal S2 cells was immunoprecipitated with 
anti-DmCaBP1 antibody and subjected to the MS analysis after digestion with trypsin (T) or 
Achromobacter protease I (A).  Peptides identified in both DmCaBP1 preparations are shown with 
dots along with the amino acid sequence of DmCaBP1 deduced from the nucleotide sequence of its 
cDNA.  Peptides including the presumed N-terminus and C-terminus of mature DmCaBP1 are 
underlined.  Refer to supplemental Fig. S3 for more information. 
 
FIGURE 3. Surface DmCaBP1-mediated phagocytosis of latex beads and non-apoptotic cells.  A, 
Cycloheximide-treated S2 cells (left) and l(2)mbn cells (right) were incubated with recombinant 
DmCaBP1 proteins fused to GST and MBP, respectively.  GST alone and MBP-βgal were included 
as controls for GST-DmCaBP1 and MBP-DmCaBP1-βgal, respectively.  The cells were recovered 
by centrifugation, and their whole-cell lysates were examined by Western blotting using anti-GST 
antibody (left) or anti-MBP antibody (right) together with the input proteins, GST-DmCaBP1/GST 
(left) and MBP-DmCaBP1-βgal/MBP-βgal (right).  B, Latex beads coated with GST-fused 
DmCaBP1 (GST-DmCaBP1) or GST alone were subjected to an assay for phagocytosis with l(2)mbn 
cells, which had been treated with double-stranded RNA (dsRNA) containing mRNA sequences of the 
indicated genes, as phagocytes.  The level of phagocytosis is shown relative to that of non-coated 
latex beads, taken as 100.  NS, not significant.  The mean ± S. D. of the data (n = 6) from one of 
three independent experiments with similar results are presented.  C, S2 cells transfected with DNA 
for the expression of GPI-anchored DmCaBP1 (GPI-DmCaBP1) or with the vector alone were 
subjected to an immunofluorescence analysis with anti-DmCaBP1 antibody under a 
membrane-nonpermeabilized condition.  Scale bar, 10 µm.  D, S2 cells analyzed in B as well as 
untransfected cells (none) were examined for susceptibility to phagocytosis by l(2)mbn cells.  Data 
are expressed as the mean ± S. D. of the results from three independent experiments (n = 3 in each 
experiment). 
 
FIGURE 4. Involvement of DmCaBP1 in apoptotic cell clearance in Drosophila.  A, 
Whole-animal lysates of adult flies generated by the mobilization of P-element were analyzed by 
Western blotting for the level of DmCaBP1.  DmCaBP1H20 and DmCaBP1∆1 are fly lines obtained 
through the precise and imprecise excision of P-element in the original fly line, respectively.  Refer 
to supplemental Fig. S4 for more information.  B, Dispersed cells prepared from stage-16 embryos of 
DmCaBP1H20 and DmCaBP1∆1 were examined for the level of phagocytosis.  Data are expressed as 
the mean ± S. D. of the results from three independent experiments (n = 5 in each experiment).  C, 
Brains dissected from DmCaBP1H20 and DmCaBP1∆1 as well as Draper-lacking (drpr∆5) flies at the 
indicated developmental stages (APF, after puparium formation) were histochemically examined for 
the existence of γ neuron axons.  The arrowheads point to the axons removed during metamorphosis.  
Scale bar, 20 µm. 
 
FIGURE 5. Functional relationship between DmCaBP1 and Pretaporter.  A, Lysates of adult 
flies of the indicated lines were analyzed by Western blotting for the levels of DmCaBP1, Pretaporter, 
and Draper.  The fly line prtp∆1 is a null-mutant for pretaporter (17).  B, Dispersed cells prepared 
from stage-16 embryos of the indicated fly lines were examined for the level of phagocytosis.  Data 
are expressed as the mean ± S. D. of the results from three independent experiments (n = 5 in each 














SUPPLEMENTAL FIGURE S1.  Identification of DmCaBP1 by MS. 
 
The protein band indicated with an arrowhead in Fig. 1A was subjected to the analysis by LC-MS/MS.  A, 
Score histogram of the summarized data is shown.  The arrow points to DmCaBP1.  The protein score was 
717 for DmCaBP1 and 41 for elongation factor, the second candidate.  B, Raw data for the identified 
peptides are shown together with the corresponding ions scores.  “Start-End” means amino acid positions of 
the peptides with the amino terminus of nascent DmCaBP1 numbered 1 (see Fig. 1B).  C, A MS/MS 









SUPPLEMENTAL FIGURE S2.  Effects of inflammatory stimulus and inhibitor of vesicle transport, 
autophagy, or proteasome on externalization of DmCaBP1. 
 
A, S2 cells were incubated in the presence and absence of cycloheximide or E. coli-derived LPS, and the 
culture media and cell lysates were analyzed by Western blotting for the presence of DmCaBP1.  The same 
cells were analyzed by RT-PCR for the levels of mRNA of attacin-A, an antimicrobial peptide, and 
ribosomal protein 49 (rp49) as an unchanged control.  B, S2 cells were treated with cycloheximide in the 
presence and absence of brefeldin A (vesicle transport inhibitor), 3-methyladenine (autophagy inhibitor), or 
MG-132 (proteasome inhibitor).  The culture media and whole-cell lysates were analyzed by Western 










SUPPLEMENTAL FIGURE S3.  DmCaBP1-derived peptides identified in MS. 
 
DmCaBP1 in whole-cell lysates of normal S2 cells (intracellular) or culture media of S2 cells undergoing 
cycloheximide-induced apoptosis (externalized) was immunoprecipitated and separated by SDS-PAGE.  
Portions of gels containing DmCaBP1 were excised and in-gel-digested with trypsin (A) or Achromobacter 
protease I (B), and the resulting peptides were subjected to LC-MS/MS.  The peak intensities of peptides 
identified in the analysis are shown, relative to the most intense peptides, with amino acid sequences.  The 
peptides including presumed C-terminus (A) and N-terminus (B) of mature DmCaBP1 are shown with a 









SUPPLEMENTAL FIGURE S4.  Structure of genomic locus near DmCaBP1 in DmCaBP1-lacking fly 
line. 
 
The structure of the genomic locus in the vicinity of DmCaBP1 in the fly lines DmCaBP1EY12345 and 
DmCaBP∆1 is schematically presented.  DmCaBP1EY12345 with insertion of P-element (EY12345) in the first 
exon of DmCaBP1 was subjected to P-element excision, resulting in the generation of DmCaBP∆1 that lacks 
the expression of DmCaBP1 (see Fig. 4A).  For unknown reasons, we were unable to completely determine 
the nucleotide sequences of the genomic locus near DmCaBP1 in the mutant line.  Therefore, the data from 
nucleotide sequencing of a portion of the first exon and the entire second exon were combined with those 
from Southern blotting analysis of genomic DNA, and the structure of this locus has been presumed to be 
either of the two shown above: there is a deletion of about 6 or 9 kbp (with parentheses) including a part of 
the first exon of DmCaBP1.  The boxes indicate exons with protein-coding regions shaded and the 
P-element striped. 
 
